Deferral of FDA consideration of enforcement discretion

The a2 Milk Company (a2MC, the Company) wishes to advise that earlier today it received notification from the US Food and Drug Administration (FDA) that, at this time, the FDA is deferring further consideration of the Company’s request for enforcement discretion to import infant milk formula (IMF) products into the US.

The Company has also subsequently been advised by the International Dairy Foods Association (IDFA) that equivalent letters have been sent to all pending enforcement discretion applicants, indicating that the FDA is deferring any further review at this time of all pending applications.

Notice of deferral of FDA consideration of enforcement discretion

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

CCC - ESQUIRES IRELAND RECOGNISED AS THE BEST IN IRISH AWARDS
FBU - Fletcher Building Quarterly Volume Report for Q3 FY26
April 16th Morning Report
SCT - 2026 Half Year Announcement
Devon Funds Morning Note - 14 April 2026
BNP Paribas accredited as Derivatives Market Maker
GXH - Response to media report
April 14th Morning Report
SML - Synlait responds to The a2 Milk Company announcement
KPG - Annual meeting date, closing date for director nominations